2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
Specimen Handling
655
pembrolizumab
605
Magnetic Resonance Spectroscopy
562
Carboplatin
445
Cisplatin
396
Cyclophosphamide
394
Biopsy
378
Nivolumab
323
Paclitaxel
320
Gemcitabine
313
Radiotherapy
293
Bevacizumab
248
Dexamethasone
221
fludarabine
212
Docetaxel
201
durvalumab
193
atezolizumab
186
Oxaliplatin
186
venetoclax
182
Fluorouracil
175
Rituximab
173
Pemetrexed
172
Capecitabine
170
Radiation
166
Doxorubicin
166
Radiosurgery
158
Ipilimumab
145
Etoposide
142
Leucovorin
140
Lenalidomide
137
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
2,2'-dithiodiethanesulfonic acid
×
90 days
×
Clear all
NCT05456256
2026-05-04
HARMONIC
Lantern Pharma Inc.
Phase 2
Recruiting
90 enrolled